CRYSTALYS LIDO (2x1,25 ml) LUMINERA
STRICTLY PROFESSIONAL USE. THE INJECTION IS AN EXCLUSIVE MEDICAL ACT.
CRYSTALYS LIDO LUMINERA is a calcium hydroxyapatite-based injectable dermal filler designed to restore facial volume and natural contours by promoting generation and deposition of natural collagen, the body's physiological soft tissue filler.
The beneficial effects of Crystalys are both immediate and long lasting. Clinical results are evident for up to 2 years, depending on the volume injected, patient skin properties and age.
Provides a volumizing, lifting effect. Extensive clinical experience. Sound safety profile.
Safe active ingredient with over a decade of marketing experience in dermal fillers. surgical implants. Biocompatible and biodegradable. Promotes generation of natural collagen.
Calcium hydroxyapatite (55.7%) microspheres of 25-45 microns diameter, Glycerin, CMC and Phosphate buffer.
Crystalys is provided in a 1.25 mL prefilled graduated syringe.
MECHANISM OF ACTION
Injected areas are filled and lifted, resulting in a superb 'on the spot' outcome.
The calcium hydroxyapatite microspheres form a scaffold supportive of fibroblast ingrowth, which, in turn, produces and deposits new collagen, a natural volumizing agent in facial regions. Calcium hydroxyapatite degradation is synchronous with neo-collagen deposition at the injection site, providing a lasting, natural, full and youthful look.
The force applied by the physician while injecting.
Eyebrow. Temple. Bridge of the nose. Cheeckbone. Nosolabial folds. Lower cheek. Oral commissures. Marionette lines. Jawline Chin /chin fold.
The next-generation dermal filler for wrinkle filling, volume lifting, skin rejuvenation and face contouring. Luminera is an R&D company, and a manufacturer of products in the aesthetic medicine field. Injectable Beauty Solutions.
The company's portfolio includes: Luminera family of products includes Hydryal (non crossed-linked HA), Hydryalix (cross linked HA), Crystalys (CaHA based filler), and HArmonyCa (CaHA embedded in a cross linked HA gel).